Clinical Trial Update: Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating first-line treatment with carboplatin plus mirvetuximab soravtansine for advanced-stage ovarian, fallopian tube, or primary perito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Mirvetuximab soravtansine (mirvetuximab soravtansine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ovarian Cancer, Fallopian Tube | Phase 2 | Status: RECRUITING